High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung Cancer
Author:
Publisher
S. Karger AG
Subject
Cancer Research,Oncology,General Medicine
Reference29 articles.
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
2. Albain KS, Swann RS, Rusch VW, et al: Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009; 374: 379–386.
3. Allen AM, Mentzer SJ, Yeap BY, et al: Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women’s Hospital experience. Cancer 2008; 112: 1106–1113.
4. Yang CJ, Mayne NR, Wang H, et al: Outcomes of major lung resection after induction therapy for non-small cell lung cancer in elderly patients. Ann Thorac Surg 2016; 102: 962–970.
5. Gandara DR, Chansky K, Albain KS, et al: Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J Clin Oncol 2003; 21: 2004–2010.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Surgical Indications for Non-Small-Cell Lung Cancer;Cancers;2022-02-28
2. Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway in vitro and in vivo;Frontiers in Pharmacology;2022-01-17
3. Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy;Radiotherapy and Oncology;2021-12
4. Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer;OncoImmunology;2021-01-01
5. Radiation Oncology of Lung Cancer: Why We Fail(ed) in Clinical Research?;Medical Radiology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3